Cargando…

Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft

Advanced cutaneous squamous cell carcinoma (cSCC) is treated with chemotherapy and/or radiotherapy, but these typically fail to achieve satisfactory clinical outcomes. There have been no preclinical studies to evaluate the effectiveness of eribulin against cSCC. Here, we examine the effects of eribu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Che-Yuan, Yanagi, Teruki, Maeda, Takuya, Nishihara, Hiroshi, Miyamoto, Kodai, Kitamura, Shinya, Tokuchi, Keiko, Ujiie, Hideyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224945/ https://www.ncbi.nlm.nih.gov/pubmed/37244956 http://dx.doi.org/10.1038/s41598-023-35811-3

Ejemplares similares

HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses
por: Tokuchi, Keiko, et al.
Publicado: (2022)

TRIM29 in Cutaneous Squamous Cell Carcinoma
por: Hsu, Che-Yuan, et al.
Publicado: (2021)

Diagnosis and Management of Porocarcinoma
por: Miyamoto, Kodai, et al.
Publicado: (2022)

Cyclin‐dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget’s disease
por: Kitamura, Shinya, et al.
Publicado: (2021)

Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma
por: Yanagi, Teruki, et al.
Publicado: (2018)

Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma
por: Maeda, Takuya, et al.
Publicado: (2023)

Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma
por: Nakano, Tomoyuki, et al.
Publicado: (2021)

TB-06 Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma
por: Nakano, Tomoyuki, et al.
Publicado: (2020)

Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the Literature
por: Kosumi, Hideyuki, et al.
Publicado: (2023)

Eribulin shows high concentration and long retention in xenograft tumor tissues
por: Sugawara, Michiko, et al.
Publicado: (2017)

Development of Verruca Plana from Human Papillomavirus 78 Dependent on Host Immune State
por: SHIMANO, Mayuna, et al.
Publicado: (2021)

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts
por: Takahashi, Masamichi, et al.
Publicado: (2019)

Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition
por: Kitahara, Hiroko, et al.
Publicado: (2016)

Elimination of tumor hypoxia by eribulin demonstrated by (18)F-FMISO hypoxia imaging in human tumor xenograft models
por: Zhao, Songji, et al.
Publicado: (2019)

Eribulin drug review
por: Shetty, Nishitha, et al.
Publicado: (2014)

Eribulin in Cancer Treatment
por: Swami, Umang, et al.
Publicado: (2015)

In vitro radiosensitization by eribulin in human cancer cell lines
por: Benlloch, Raquel, et al.
Publicado: (2022)

Selectively high efficacy of eribulin against high-grade invasive recurrent and/or metastatic squamous cell carcinoma of the head and neck
por: Kobayashi, Yutaka, et al.
Publicado: (2019)

Stathmin dynamics modulate the activity of eribulin in breast cancer cells
por: Yoshie, Mikihiro, et al.
Publicado: (2021)

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
por: Ho, Gwo Yaw, et al.
Publicado: (2023)

Malignant Adenomyoepithelioma of the Breast and Responsiveness to Eribulin
por: Lee, Suee, et al.
Publicado: (2015)

Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)

Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer
por: Udagawa, Hibiki, et al.
Publicado: (2022)

Regulation of programmed cell death ligand 1 expression by atypical protein kinase C lambda/iota in cutaneous angiosarcoma
por: Kawamura, Ai, et al.
Publicado: (2019)

Endoscopic submucosal dissection for early squamous cell carcinoma in the anal canal and Lugol chromoendoscopy for assessment of the lateral margin
por: Uozumi, Takeshi, et al.
Publicado: (2018)

Tumor xenograft animal models for esophageal squamous cell carcinoma
por: Lee, Nikki P., et al.
Publicado: (2018)

Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy
por: Helfrich, Barbara A., et al.
Publicado: (2018)

A randomized trial of eribulin monotherapy versus eribulin plus anlotinib in patients with locally recurrent or metastatic breast cancer
por: Liu, B., et al.
Publicado: (2023)

Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody
por: Niwa, Yuki, et al.
Publicado: (2023)

Cutaneous Spindle Cell Squamous Cell Carcinoma
por: Lee, Joo Hee, et al.
Publicado: (2015)

Retinoids in Cutaneous Squamous Cell Carcinoma
por: Everts, Helen B., et al.
Publicado: (2021)

Eribulin targets a ch-TOG-dependent directed migration of cancer cells
por: Chanez, Brice, et al.
Publicado: (2015)

Eribulin Mesylate Targets Human Telomerase Reverse Transcriptase in Ovarian Cancer Cells
por: Yamaguchi, Satoko, et al.
Publicado: (2014)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain, Sarika, et al.
Publicado: (2012)

An α-chloroaldehyde-based formal synthesis of eribulin
por: Kaghad, Anissa, et al.
Publicado: (2023)

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)

Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts
por: Morisada, Shinya, et al.
Publicado: (1989)

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
por: Garrone, Ornella, et al.
Publicado: (2016)

Anti-Malignant Effect of Tensile Loading to Adherens Junctions in Cutaneous Squamous Cell Carcinoma Cells
por: Dobrokhotov, Oleg, et al.
Publicado: (2021)

Continued Chemotherapy After Concurrent Chemoradiotherapy Improves Treatment Outcomes for Unresectable Cutaneous Squamous Cell Carcinoma: An Analysis of 13 Cases
por: Hiura, Azusa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ukadlc8ki4okbft0dg3nfng397